(Q43563762)

24 November 2017

title

The value of electrophysiology results in patients with epilepsy and vigabatrin associated visual field loss (English)

1 reference

24 November 2017

1 reference

Hardus P

1

1 reference

24 November 2017

Verduin WM

2

1 reference

24 November 2017

Berendschot TT

3

1 reference

24 November 2017

Kamermans M

4

1 reference

24 November 2017

Postma G

5

1 reference

24 November 2017

Stilma JS

6

1 reference

24 November 2017

van Veelen CW

7

1 reference

24 November 2017

language of work or name

1 reference

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

79

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

169-174

1 reference

Symptomatic and asymptomatic visual loss in patients taking vigabatrin.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.079002169.X

Concentric contraction of the visual field in patients with temporal lobe epilepsy and its association with the use of vigabatrin medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.079002169.X

Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.079002169.X

Visual function loss from vigabatrin: effect of stopping the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.079002169.X

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.079002169.X

Visual field defects associated with vigabatrin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.079002169.X

Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.079002169.X

Outer retinal dysfunction in patients treated with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.079002169.X

7 January 2021

Severe persistent visual field constriction associated with vigabatrin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.079002169.X

7 January 2021

Visual electrophysiological effect of a GABA transaminase blocker

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.079002169.X

7 January 2021

Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2001.079002169.X

7 January 2021

10.1034/J.1600-0420.2001.079002169.X

Identifiers

DOI

1 reference

24 November 2017

1 reference